E Arbustini, M Grasso, G Leo, C Tinelli, R Fasani, M Diegoli, N Banchieri, A Cipriani, M Gorrini, G Semenzato and M Luisetti
Istituto di Anatomia Patologica, Universita di Pavia, IRCCS Policlinico San Matteo, Italy.

Sarcoidosis is the disease in which increased levels of serum Angiotensin-converting enzyme (sACE) are most often detected. It has recently been shown that the deletion (D) or the insertion (I) of a 250bp-DNA fragment in the ACE gene accounts for three main ACE genotypes (i.e., II, ID, and DD) and for 47% of total phenotypic variance in sACE level. The aim of our work was to investigate whether or not patients with sarcoidosis have an increased incidence of those ACE genotypes coding for highest sACE levels and to investigate whether or not sACE level in sarcoidosis is related to ACE genotypes. We studied 61 unrelated patients with sarcoidosis (test group) and 80 unrelated healthy control subjects (control group). The ACE I and D alleles were detected with polymerase chain reaction on genomic DNA. In the control group we found an ACE genotype distribution that agreed with the Hardy-Weinberg proportion. The ACE genotype distribution was not significantly different in the test group. There was no correlation between ACE genotype and roentgenologic stage of sarcoidosis. Plotting the sACE level in the control group against ACE genotype, we found a trend of increasing mean sACE value according to the order II < ID < DD. The same trend for ACE genotype was found in the test group, in which it also paralleled the trend of sACE values plotted against roentgenologic stage, according to the order Stage I < Stage II < Stage III. We conclude that in sarcoidosis the ACE genotype distribution is not altered. The trends for increasing sACE values in sarcoidosis according to both ACE genotype and roentgenologic stage would suggest that both mechanisms play a role in determining sACE level.

This article has been cited by other articles:

				I. Campo, P. Morbini, M. Zorzetto, C. Tinelli, E. Brunetta, C. Villa, C. Bombieri, M. Cuccia, C. Agostini, V. Bozzi, et al. Expression of Receptor for Advanced Glycation End Products in Sarcoid Granulomas Am. J. Respir. Crit. Care Med., March 1, 2007; 175(5): 498 - 506. [Abstract] [Full Text] [PDF]

				M. C. Iannuzzi and B. A. Rybicki Genetics of Sarcoidosis: Candidate Genes and Genome Scans Proceedings of the ATS, January 1, 2007; 4(1): 108 - 116. [Abstract] [Full Text] [PDF]

				B.A. Rybicki, M.J. Maliarik, L.M. Poisson, and M.C. Iannuzzi Sarcoidosis and granuloma genes: a family-based study in African-Americans Eur. Respir. J., August 1, 2004; 24(2): 251 - 257. [Abstract] [Full Text] [PDF]

				K. Psathakis, G. Papatheodorou, M. Plataki, P. Panagou, S. Loukides, N. M. Siafakas, and D. Bouros 8-Isoprostane, a Marker of Oxidative Stress, Is Increased in the Expired Breath Condensate of Patients With Pulmonary Sarcoidosis Chest, March 1, 2004; 125(3): 1005 - 1011. [Abstract] [Full Text] [PDF]

				R. M. du Bois The Genetic Predisposition to Interstitial Lung Disease : Functional Relevance Chest, March 1, 2002; 121(2007): 14S - 20S. [Abstract] [Full Text] [PDF]

				B. A. RYBICKI, M. C. IANNUZZI, M. M. FREDERICK, B. W. THOMPSON, M. D. ROSSMAN, E. A. BRESNITZ, M. L. TERRIN, D. R. MOLLER, J. BARNARD, R. P. BAUGHMAN, et al. Familial Aggregation of Sarcoidosis . A Case-Control Etiologic Study of Sarcoidosis (ACCESS) Am. J. Respir. Crit. Care Med., December 1, 2001; 164(11): 2085 - 2091. [Abstract] [Full Text] [PDF]

				D. S. McGRATH, P. J. FOLEY, M. PETREK, L. IZAKOVICOVA-HOLLA, V. DOLEK, S. VEERARAGHAVAN, P. A. LYMPANY, P. PANTELIDIS, A. VASKU, A. U. WELLS, et al. ACE Gene I/D Polymorphism and Sarcoidosis Pulmonary Disease Severity Am. J. Respir. Crit. Care Med., July 15, 2001; 164(2): 197 - 201. [Abstract] [Full Text] [PDF]

				G.M. Verleden, R.M. du Bois, D. Bouros, M. Drent, A. Millar, J. Muller-Quernheim, G. Semenzato, S. Johnson, G. Sourvinos, D. Olivieri, et al. Genetic predisposition and pathogenetic mechanisms of interstitial lung diseases of unknown origin Eur. Respir. J., July 1, 2001; 18(32_suppl): 17S - 29s. [Abstract] [Full Text] [PDF]

				U. Costabel Sarcoidosis: clinical update Eur. Respir. J., July 1, 2001; 18(32_suppl): 56S - 68s. [Abstract] [Full Text] [PDF]

				J. Grunewald and A. Eklund Human leukocyte antigen genes may outweigh racial background when generating a specific immune response in sarcoidosis Eur. Respir. J., May 1, 2001; 17(5): 1046 - 1048. [Abstract] [Full Text] [PDF]

				B. Agerholm-Larsen, B. G. Nordestgaard, and A. Tybjarg-Hansen ACE Gene Polymorphism in Cardiovascular Disease : Meta-Analyses of Small and Large Studies in Whites Arterioscler. Thromb. Vasc. Biol., February 1, 2000; 20(2): 484 - 492. [Abstract] [Full Text] [PDF]

				L. A. MAIER, M. V. RAYNOLDS, D. A. YOUNG, E. A. BARKER, and L. S. NEWMAN Angiotensin-1 Converting Enzyme Polymorphisms in Chronic Beryllium Disease Am. J. Respir. Crit. Care Med., April 1, 1999; 159(4): 1342 - 1350. [Abstract] [Full Text] [PDF]

				M. J. MALIARIK, B. A. RYBICKI, E. MALVITZ, R. G. SHEFFER, M. MAJOR, J. POPOVICH Jr., and M. C. IANNUZZI Angiotensin-converting Enzyme Gene Polymorphism and Risk of Sarcoidosis Am. J. Respir. Crit. Care Med., November 1, 1998; 158(5): 1566 - 1570. [Abstract] [Full Text] [PDF]

				B G MARSHALL and R J SHAW Association between angiotensin II receptor gene polymorphism and serum angiotensin converting enzyme (SACE) activity in patients with sarcoidosis Thorax, June 1, 1998; 53(6): 439 - 440. [Full Text]

				H. TOMITA, Y. INA, Y. SUGIURA, S. SATO, H. KAWAGUCHI, M. MORISHITA, M. YAMAMOTO, and R. UEDA Polymorphism in the Angiotensin-Converting Enzyme (ACE) Gene and Sarcoidosis Am. J. Respir. Crit. Care Med., July 1, 1997; 156(1): 255 - 259. [Abstract] [Full Text]

				L. S. Newman, C. S. Rose, and L. A. Maier Sarcoidosis N. Engl. J. Med., April 24, 1997; 336(17): 1224 - 1234. [Full Text] [PDF]